retatrutide trial update october 2025 How to Get in 2026 ADA 2026: Retatrutide Revolution

Cindy G

GLP-1 receptor agonist (RA) medications work by mimicking natural hormones that promote feelings of fullness, helping to reduce calorie intake

What are the common side effects of GLP-1 therapies

Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs

She said compounders can only obtain active pharmaceutical ingredients from FDA-registered manufacturers and must conduct multiple quality control and safety tests on the batches of compounded drugs they make

But they also represent one of the most significant cost risks to employer health insurance plans heading into the 2026 renewal cycle